{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:49:10Z","timestamp":1782254950916,"version":"3.54.5"},"update-to":[{"DOI":"10.1002\/14651858.cd010233.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000}}],"reference-count":86,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010233.pub3","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T16:44:47Z","timestamp":1566233087000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease"],"prefix":"10.1002","volume":"2019","author":[{"given":"Teuta","family":"Gjuladin-Hellon","sequence":"first","affiliation":[{"name":"University of Central Lancashire; School of Medicine; Preston Lancashire UK PR1 7BH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zipporah","family":"Iheozor-Ejiofor","sequence":"additional","affiliation":[{"name":"University of Central Lancashire; School of Medicine; Preston Lancashire UK PR1 7BH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris","family":"Gordon","sequence":"additional","affiliation":[{"name":"University of Central Lancashire; School of Medicine; Preston Lancashire UK PR1 7BH"},{"name":"Blackpool Victoria Hospital; Families Division; Blackpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony K","family":"Akobeng","sequence":"additional","affiliation":[{"name":"Sidra Medicine; PO Box 26999 Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,8,6]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD010233.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1053\/j.gastro.2004.06.051","article-title":"Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease","volume":"127","author":"Ardizzone","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0002|cit2","first-page":"S856","article-title":"Infliximab is more effective than azathioprine in the long-term prevention of postoperative recurrence of Crohn's disease","volume":"1","author":"Armuzzi","year":"April 2015","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1016\/S1590-8658(12)60550-7","article-title":"Prevention of postoperative recurrence with azathioprine or anti-TNF alpha in patients with Crohn's disease: A pilot study","volume":"44","author":"Armuzzi","year":"2012","journal-title":"Digestive and Liver Disease"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD010233.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"S780","DOI":"10.1016\/S0016-5085(12)63025-X","article-title":"Prevention of postoperative recurrence with azathioprine or anti-TNF alpha in patients with Crohn's disease: An open-label pilot study","volume":"142","author":"Armuzzi","year":"2012","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD010233.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1016\/j.crohns.2013.04.020","article-title":"Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study","volume":"7","author":"Armuzzi","year":"2013","journal-title":"Journal of Crohn's and Colitis"},{"issue":"4","key":"10.1002\/14651858.CD010233.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1053\/j.gastro.2008.07.010","article-title":"Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial","volume":"135","author":"D'Haens","year":"2008","journal-title":"Gastroeneterology"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD010233.pub3-BIB0007|cit7","first-page":"A52","article-title":"Combination therapy with metronidazole and azathioprine reduces severe postoperative recurrence of Crohn's disease: A double-blind controlled randomized trial","volume":"132","author":"D'Haens","year":"2007","journal-title":"Gastroenterology 2007"},{"issue":"3","key":"10.1002\/14651858.CD010233.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1053\/j.gastro.2004.06.002","article-title":"Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine or placebo: a 2-year trial","volume":"127","author":"Hanauer","year":"2004","journal-title":"Gastroenterology"},{"issue":"4 Part 2","key":"10.1002\/14651858.CD010233.pub3-BIB0009|cit9","first-page":"A486","article-title":"Post-operative prophylaxis with 6-MP, 5-ASA or placebo inCrohn's disease: A 2 year multicenter trial","volume":"114","author":"Korelitz","year":"1998","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD010233.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FTD.0b013e3180312b9a","article-title":"Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine","volume":"29","author":"Dilger","year":"2007","journal-title":"Therapeutic Drug Monitoring"},{"issue":"4 Suppl 2","key":"10.1002\/14651858.CD010233.pub3-BIB0011|cit11","first-page":"A480","article-title":"Double-blind, double dummy, randomized, multicentre, comparative study on the efficacy and safety of azathioprine (AZA) versus mesalazine (5-ASA) for prevention of postoperative endoscopic recurrence in Crohn\u2019s disease","volume":"130","author":"Herfarth","year":"2006","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD010233.pub3-BIB0012|cit12","first-page":"1526","article-title":"Adverse events in clinical trials with azathioprine and mesalamine for the prevention of postoperative recurrence of Crohn's disease","volume":"55","author":"Herfarth","year":"2006","journal-title":"Gut"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0013|cit13","unstructured":"Muller R Herfarth H More information on 2006 study published in Gut Email to Morris Gordon"},{"issue":"11","key":"10.1002\/14651858.CD010233.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1293\u2013301","DOI":"10.1093\/ecco-jcc\/jjx051","article-title":"Adalimumab vs azathioprine in the prevention of postoperative Crohn\u2019s disease recurrence. A GETECCU randomised trial","volume":"11","author":"Lopez-Sanroman","year":"2017","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0015|cit15","first-page":"A3","article-title":"Apprecia: Adalimumab vs azathioprine in the prevention of Crohn's disease recurrence after surgical resection. A geteccu multicenter randomized trial","volume":"1","author":"Lopez-Sanroman","year":"2015","journal-title":"United European Gastroenterology Journal"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0016|cit16","unstructured":"NCT01564823 Adalimumab on Preventing Post-chirurgic Recurrence on Crohn's Disease (APPRECIA) clinicaltrials.gov\/ct2\/show\/NCT01564823"},{"issue":"4","key":"10.1002\/14651858.CD010233.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.dld.2019.01.002","article-title":"Quality of life during one year of postoperative prophylactic drug therapy after intestinal resection in Crohn's patients: Results of the APPRECIA trial","volume":"51","author":"Taxonera","year":"2019","journal-title":"Digestive and Liver Disease"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010233.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"A43","DOI":"10.1136\/gutjnl-2016-312388.71","article-title":"The toppic trial: A randomised, double-blind parallel group trial of mercaptopurine vs placebo to prevent recurrence of Crohn's disease following surgical resection in 240 patients","volume":"65","author":"Arnott","year":"2016","journal-title":"Gut"},{"issue":"1 Supplement","key":"10.1002\/14651858.CD010233.pub3-BIB0019|cit19","first-page":"S21","article-title":"The TOPPIC trial: A randomised, double-blind parallel-group trial of mercaptopurine versus placebo to prevent recurrence of Crohn's disease following surgical resection in 240 patients","volume":"10","author":"Arnott","year":"2016","journal-title":"Journal of Crohn's and Colitis"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD010233.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1016\/S0016-5085(16)30696-5","article-title":"The toppic trial: A randomized, double-blind parallel group trial of mercaptopurine vs placebo to prevent recurrence of Crohn's disease following surgical resection in 240 patients","volume":"150","author":"Arnott","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0021|cit21","unstructured":"ISRCTN89489788 Randomised controlled trial of 6-Mercaptopurine (6MP) versus placebo to prevent recurrence of Crohn's disease following surgical resection isrctn.com\/ISRCTN89489788"},{"issue":"4","key":"10.1002\/14651858.CD010233.pub3-BIB0022|cit22","first-page":"273","article-title":"Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): A multicentre, double-blind, randomised controlled trial","volume":"1","author":"Mowat","year":"2016","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/MIB.0b013e31827eea8b","article-title":"Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels","volume":"19","author":"Angelberger","year":"2013","journal-title":"Inflammatory Bowel Diseases"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD010233.pub3-BIB0024|cit24","first-page":"S685","article-title":"Relationship between thiopurine metabolite levels and endoscopic improvement in patients with postoperative moderate to severe endoscopic recurrence of Crohn'sdisease","volume":"138","author":"Angelberger","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0025|cit25","unstructured":"NCT00946946 Preventing postoperative relapse in Crohn's disease patients at risk: Azathioprine versus mesalazine clinicaltrials.gov\/ct2\/show\/NCT00946946"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD010233.pub3-BIB0026|cit26","first-page":"A70","article-title":"A double-blind, double-dummy,randomized, controlled, multicenter trial on the efficacy and safety of azathioprine vs mesalamine for prevention of clinical relapses in Crohn's disease patients with postoperative moderate or severe endoscopic recurrence","volume":"134","author":"Reinisch","year":"2008","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD010233.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/gut.2009.194159","article-title":"Azathioprine versus mesalazine for the prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomized, double-blind, double-dummy, multicentre trial","volume":"59","author":"Reinisch","year":"2010","journal-title":"Gut"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1016\/S1873-9946(13)60629-7","article-title":"Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in Crohn's disease patients with endoscopic recurrence: Follow-up data of a randomised, double-blind, double-dummy, 1-year, multicentre trial","volume":"7","author":"Reinisch","year":"2013","journal-title":"Journal of Crohn's and Colitis"},{"issue":"5","key":"10.1002\/14651858.CD010233.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/gut.2010.226928","article-title":"Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease - the authors' response","volume":"60","author":"Reinisch","year":"2011","journal-title":"Gut"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0030|cit30","doi-asserted-by":"crossref","unstructured":"Bodini G Pellegatta G Giannini EG Savarino V Savarino EV Adalimumab therapy rather than azathioprine and mesalamine is able to halt Crohn's disease progression after resective surgery and a post-hoc analysis of a prospective randomized study Gastroenterology 2017 S774","DOI":"10.1016\/S0016-5085(17)32685-9"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0032|cit31","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/S1590-8658(13)60261-3","article-title":"Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease - a randomized trial","volume":"45","author":"Savarino","year":"2013","journal-title":"Digestive and Liver Disease"},{"issue":"11","key":"10.1002\/14651858.CD010233.pub3-BIB0031|cit32","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/ajg.2013.287","article-title":"Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial","volume":"108","author":"Savarino","year":"2013","journal-title":"American Journal of Gastroenterology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD010233.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0016-5085(13)60072-4","article-title":"Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease - a randomized trial","volume":"144","author":"Savarino","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0034|cit34","unstructured":"NCT01629628 Adalimumab for the Management of Post-operative Crohn's Disease (CD) POPART clinicaltrials.gov\/ct2\/show\/NCT01629628"},{"issue":"4 Supplement","key":"10.1002\/14651858.CD010233.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1016\/S0016-5085(15)30790-3","article-title":"Early initiation of adalimumab significantly diminishes post-operative Crohn's disease recurrence, and is superior to immunomodulator therapy. Preliminary results from the POPART trial","volume":"148","author":"Scapa","year":"2015","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD010233.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/ecco-jcc\/jjv076","article-title":"Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease Recurrence","volume":"9","author":"Ferrante","year":"2015","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1016\/S1873-9946(14)60458-X","article-title":"Systematic versus endoscopy-driven treatment with azathioprine to prevent postoperative ileal Crohn's disease recurrence","volume":"8","author":"Ferrante","year":"2014","journal-title":"Journal of Crohn's and Colitis"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD010233.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"S592","DOI":"10.1016\/S0016-5085(14)62145-4","article-title":"Systematic versus endoscopy-driven treatment with azathioprine to prevent postoperative ileal crohn's disease recurrence: Interim results from a randomized, multicenter trial","volume":"146","author":"Ferrante","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0040|cit39","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S1873-9946(12)60230-X","article-title":"Azathioprine versus azathioprine plus metronidazole for the prevention of postoperative endoscopic recurrence of Crohn's disease: A randomized, placebo controlled trial","volume":"6","author":"Manosa","year":"2012","journal-title":"Journal of Crohn's and Colitis"},{"issue":"9","key":"10.1002\/14651858.CD010233.pub3-BIB0039|cit40","first-page":"1889","article-title":"Addition of metronidazole to azathioprine for the prevention of postoperative recurrence of Crohn's disease: a randomized, double-blind, placebo-controlled trial","volume":"19","author":"Ma\u00f1osa","year":"2013","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0041|cit41","unstructured":"NCT01876264 Crohn's extent of resection trial clinicaltrials.gov\/ct2\/show\/NCT01876264"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0042|cit42","unstructured":"NCT02247258 Azathioprine in the prevention of ileal Crohn's disease postoperative recurrence clinicaltrials.gov\/ct2\/show \/NCT02247258"},{"issue":"8","key":"10.1002\/14651858.CD010233.pub3-BIB0043|cit43","first-page":"374","article-title":"Azathiprine and 5-ASA in the prevention of postoperative recurrence in Crohn's disease","volume":"23","author":"Nos","year":"2000","journal-title":"Gastroenterolog\u00eda y Hepatolog\u00eda"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1016\/S1873-9946(13)60629-7","article-title":"Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in Crohn's disease patients with endoscopic recurrence: Follow-up data of a randomised, double-blind, double-dummy, 1-year, multicentre trial","volume":"7","author":"Reinisch","year":"2013","journal-title":"Journal of Crohn's and Colitis"},{"issue":"2","key":"10.1002\/14651858.CD010233.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00384-014-1984-x","article-title":"Long-term prevention of postoperative Crohn's disease recurrence with azathioprine: the wolf in the sheep clothing","volume":"30","author":"Robb","year":"2015","journal-title":"International Journal of Colorectal Disease"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.12659\/MSM.890975","article-title":"Azathioprine is more effective than mesalazine at preventing recurrent bowel obstruction in patients with ileocecal Crohn's disease","volume":"20","author":"Vidigal","year":"2014","journal-title":"Medical Science Monitor"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD010233.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"S435","DOI":"10.1016\/S0016-5085(14)61564-X","article-title":"Intestinal resection in Crohn's disease is associated with significant and durable improvement in health related quality of life although to a lesser extent in women and smokers. Results from the POCER study","volume":"146","author":"Wright","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0048|cit48","first-page":"145","article-title":"Structured post-operative treatment and monitoring to prevent Crohn's disease recurrence is cost effective. Results from the POCER study","volume":"30","author":"Wright","year":"2015","journal-title":"Journal of gastroenterology and hepatology"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0049|cit49","unstructured":"NCT01015391 Efficacy study of T2 versus AZA to maintain clinical and endoscopic remission in postoperative Crohn's disease clinicaltrials.gov\/ct2\/show\/NCT01015391"},{"issue":"1","key":"10.1002\/14651858.CD010233.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.dld.2014.09.008","article-title":"Tripterygium wilfordii Hook. f. versus azathioprine for prevention of postoperative recurrence in patients with Crohn's disease: a randomized clinical trial","volume":"47","author":"Zhu","year":"2015","journal-title":"Digestive & Liver Disease"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0051|cit51","unstructured":"NCT03185611 Effectiveness of rifaximin combined with thiopurine on preventing postoperative recurrence in Crohn's disease clinicaltrials.gov\/ct2\/show\/NCT03185611"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0052|cit52","unstructured":"NL1344 Azathioprine maintenance treatment versus infliximab maintenance treatment in Crohn\u2019s disease patients in remission (Azorix trial) trialregister.nl\/trial\/1344"},{"issue":"21","key":"10.1002\/14651858.CD010233.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory Bowel Disease","volume":"361","author":"Abraham","year":"2009","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3748\/wjg.v22.i46.10103","article-title":"Thiopurines and inflammatory bowel disease: current evidence and a historical perspective","volume":"22","author":"Axelrad","year":"2016","journal-title":"World Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD010233.pub3-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002913.pub2","article-title":"Budesonide for maintenance of remission in Crohn's disease","author":"Benchimol","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD010233.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00000658-200001000-00006","article-title":"Risk factors for surgery and postoperative recurrence in Crohn\u2019s disease","volume":"231","author":"Bernell","year":"2000","journal-title":"Annals of Surgery"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0057|cit57","doi-asserted-by":"crossref","DOI":"10.1002\/9780470743386","volume-title":"Introduction to meta-analysis","author":"Borenstein","year":"2009"},{"issue":"4","key":"10.1002\/14651858.CD010233.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.cgh.2012.10.038","article-title":"Long-term outcome of patients with Crohn\u2019s disease who respond to azathioprine","volume":"11","author":"Camus","year":"2013","journal-title":"Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association"},{"issue":"10","key":"10.1002\/14651858.CD010233.pub3-BIB0059|cit59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000067.pub3","article-title":"Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease","author":"Chande","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD010233.pub3-BIB0060|cit60","first-page":"362","article-title":"The role of leukopenia in the 6-mercaptopurine induced remission of refractory Crohn's disease","volume":"89","author":"Colonna","year":"1994","journal-title":"American Journal of Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD010233.pub3-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006873.pub2","article-title":"Interventions for prevention of post-operative recurrence of Crohn's disease","author":"Doherty","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0062|cit62","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926","volume-title":"Systematic reviews in health care: Meta-analysis in context","author":"Egger","year":"2001"},{"issue":"4","key":"10.1002\/14651858.CD010233.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/gut.50.4.485","article-title":"The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review","volume":"50","author":"Fraser","year":"2002","journal-title":"Gut"},{"issue":"2","key":"10.1002\/14651858.CD010233.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ecco-jcc\/jjw169","article-title":"3rd European Evidenced-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2; Surgical Management and Special Situations","volume":"11","author":"Gionchetti","year":"February 2017","journal-title":"Journal of Crohn's and Colitis"},{"issue":"6","key":"10.1002\/14651858.CD010233.pub3-BIB0065|cit65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008414.pub3","article-title":"Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease","author":"Gjuladin-Hellon","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","article-title":"3rd European evidence-based consensus on the management of Crohn\u2019s disease 2016: Part 1: Diagnosis and medical management.","volume":"11","author":"Gomoll\u00f3n","year":"2017","journal-title":"Journal of Crohn's & Colitis"},{"issue":"1","key":"10.1002\/14651858.CD010233.pub3-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008414.pub2","article-title":"Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease","author":"Gordon","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7650","key":"10.1002\/14651858.CD010233.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD010233.pub3-BIB0069|cit69","first-page":"17","article-title":"Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate","volume":"26","author":"Hafraoui","year":"2002","journal-title":"Gastroenterologie Clinique et Biologique"},{"issue":"3","key":"10.1002\/14651858.CD010233.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1572-0241.2001.03671.x","article-title":"Management of Crohn\u2019s disease in adults","volume":"96","author":"Hanauer","year":"2001","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0071|cit71","article-title":"Chapter 8: Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Higgins","year":"2011. Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD010233.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/clpt.1989.119","article-title":"Pharmacogenitics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism","volume":"46","author":"Lennard","year":"1989","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD010233.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF02220605","article-title":"The clinical pharmacology of 6-mercaptopurine","volume":"43","author":"Lennard","year":"1992","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0074|cit74","unstructured":"National Institute of Health and Care Excellence Crohn's Disease: management (CG152) Available: https:\/\/www.nice.org.uk\/guidance\/cg152\/evidence\/addendum-pdf-2489565421 2016"},{"issue":"2","key":"10.1002\/14651858.CD010233.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"441\u201350","DOI":"10.1053\/j.gastro.2008.10.051","article-title":"Infliximab prevents Crohn's disease recurrence after ileal resection","volume":"136","author":"Regueiro","year":"2009","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD010233.pub3-BIB0076|cit76","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004826.pub2","article-title":"Probiotics for maintenance of remission in Crohn's disease","author":"Rolfe","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD010233.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/0016-5085(90)90613-6","article-title":"Predictability of the postoperative course of Crohn\u2019s disease","volume":"99","author":"Rutgeerts","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00228-008-0478-6","article-title":"Clinical pharmacology and pharmacogenetics of thiopurines","volume":"64","author":"Sahasranaman","year":"2008","journal-title":"European Journal ofClinical Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD010233.pub3-BIB0079|cit79","first-page":"423","article-title":"A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate","volume":"91","author":"Sandborn","year":"1996","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0080|cit80","article-title":"Chapter 12: Interpreting results and drawing conclusions","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Sch\u00fcnemann","year":"2011. Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD010233.pub3-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000301","article-title":"Corticosteroids for maintenance of remission in Crohn\u2019s disease","author":"Steinhart","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010233.pub3-BIB0082|cit82","volume-title":"Methods for meta-analysis in medical research","author":"Sutton","year":"2000"},{"issue":"5","key":"10.1002\/14651858.CD010233.pub3-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000478.pub4","article-title":"Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis","author":"Timmer","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD010233.pub3-BIB0084|cit84","first-page":"651","article-title":"Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity","volume":"32","author":"Weinshilboum","year":"1980","journal-title":"American Journal of Human Genetics"},{"issue":"1","key":"10.1002\/14651858.CD010233.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/bjs.1800780106","article-title":"Recurrence of Crohn's disease after resection","volume":"78","author":"Williams","year":"1990","journal-title":"British Journal of Surgery"},{"issue":"8","key":"10.1002\/14651858.CD010233.pub3-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010233.pub2","article-title":"Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease","author":"Gordon","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD010233.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T17:06:50Z","timestamp":1703092010000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010233.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane IBD Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,8,6]]},"references-count":86,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010233.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,6]]}}}